A quantitative mRNA analysis has been developed for the different tafazzin splice variants, and this should make it possible to compare mRNA levels in the cells and/or tissues of control subjects and BTHS patients, and, therefore, determine whether there is at least a correlation between mRNA levels and genotype, if known. The gene discussed is TAFAZZIN; the disease is Barth syndrome.